Hemophagocytic Syndrome: An Analysis of 7 Cases and the Literatures Review

Authors

  • Tanomsri Srichaikul Department of Medicine, Vichaiyut Hospital
  • Sompone Punyagupta Department of Medicine, Vichaiyut Hospital
  • Wichian Mongkolsritragoon Mongkolsritragoon Department of Medicine, Pramongkulklau Hospital, and Hematology Consultant at Vichaiyut Hospital
  • Suwannee Jidpugdeebodin Department of Medicine, Vichaiyut Hospital

Keywords:

Hemophagocytic syndrome, Malignant lymphoma, Epstein Barr virus

Abstract

Abstract: We reported seven hemophagocytic syndrome patients six males and one females, age ranges between 16-75 years (mean 59 years) admitted at Vichaiyut hospital during 1999-2003. Of these 7 cases, three were caused by infections (bacteria - 2, EBV - 1). The other four patients had malignant Iymphoma (ML) (T-ML-2, B-MI-2). Five patients died between 5 days - one month after
diagmosis of HPCS. Three of these five cases died because of delayed diagnosis of HPCS at terminal event lead to multiorgan failure (bacteria - 2, B-ML - 1). The other 2 cases had early diagmosis of HPCS. However, one died because of inadecuate treatment of HPCS. The another case had full treatment of HPCS and T-ML but died of refactory T-ML. Both of these two cases had EBV which
was unrecognised until the terminal event. Among four patients who had ML-HPCS, EBV genome were found in two cases (B-ML- 1 case, T-ML - 1 case). Both of these two cases died shortly after the diagmosis of HPCS. The other two maligmant lymphoma without EBV survived ; one case (T-ML) lived for 12 months and died later because of disease. The another B-ML is still alive and in complete remission up to 40 months. From this analysis, we stress the most two important factors to save life of the HPC'S patients ; the early diagnosis and the immediate treatment for HPCS as well as for the etiologic infective agent. EBV is another factor to play an important role on the outcome of HPC'S and maligmant Iymphoma and should be seriously awared of.

Downloads

Download data is not yet available.

References

Chandra P, Chaudhery SA, Rosner F, Kagen M. Thransient histiocytosis with striking phagocytosis of platelets, leukooytes, and erythrooytes. Arch Intern Med 1975;135:989-91.

Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL, Brunning RD. Virus-associated hemophagooytio syndrome: A benign histiocytio proliferation distinot from malignant histiocytosis. Cancer 1979,44:993-1002.

Reiner A, Spivak J. Hematophagio histiocytosis. Medicine 1988:67:369-88

Sullivan JL, Woda BA, Herrod HG, Koh G, Rivara FP, Mulder C. Reactive hemophagocytio syndrome; virological and immunopathological studies. Blood 1985.65:1097-104.

Veerakul G, Sanpakit K, Tanphaichitr V, Mahasandona C, Jiraratanasopa N. Secondary hemophagocytio lymphohistiocytoiss in children : an analysis of etiology and outcome. J Med Assoo Thai 2002:85:S531-S540.

Ningsanond V. Infection associated hemophagocytio syndrome : A report of 50 children. J Med Assoo Thai 2000;83:1141-9.

Kawauchi K, Ogasawara T, Yasuyama M. Clinical characterization of B cell lymphoma-associated hemophagocytio syndrome. Nihon Rinsho Meneki Gakkai Kaishi 2000:23:454-61.

Wong K, Chan JKC. Reactive hemophagocytio syndrome - a clinicopathologic study of 40 patients in an oriental population. Am J Med 1992,93:177-80.

Takahashi N, Chubachi A, Miura I, Nakamura S, Miura AB. Lymphoma associated hemophagocytic syndrome in Japan. Rinsho Ketsueki 1999;40:542-9.

Baraldes MA, Domingo P, Gonzalez MJ, Aventin A, Coll P. Tuberculosis-associated hemophagocytic syndrome in patients with acquired immunodeficiency syndrome. Arch Intern Med 1998;158:194-5.

Yashima A, Narigasawa Y, Ishida Y, Uchiyama T, Oyake T, Enomoto S, Kaneko J, Ono Y, Sugawara T, Numaoka H, Shimosegawa K, Murai K, Itoh S, Ito T, Kuriya S. Hemophagocytic syndrome due to millary tuberculosis in the course of aplastic anemia. Rinsho Ketsueki-Japanese J clini Hematol 1998;39:392-7.

Oyaizu H, Yosimura C, Wakayama T, Okamoto K, Imanaka M, Kubo Y, Nisizaka Y, Oda Y. Hemophagocytic syndrome associated with tuberculosis and mycoplasma infection in two patients. Nihon Kokyki Gakkai Zasshi 1998;36:787-92.

Chien YH, Lee PI, Huang LM, Lee CY, Lin DT, Lin KH. Typhoid fever presenting as infection-associated hemophagocytic syndrome: report of one case. Acta Paediatr Taiwan 1999,40:339-40.

Chokephaibulkit K, Veerakul G, Vanprapar N, Chaiprasert A, Tanphaichitr V, Chearskul S. Penicilliosis-associated hemophagocytic syndrome in a human immunodeficiency virus-infected child: the first case report in children. J Med Assoc Thai 2001,84:426-9.

Srichaikul T. (unpublished observation)

Marie-Helene G, Claire G, Jean Louis S. Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children - a series of 12 cases. Pediatrics 2000;106.e58.

Risdall RJ, brunning RD, Hermandez JL, Gordon DH. Bacterial associated hemophagocytic syndrome. Cancer 1984;54:2968-72.

Eakle JF, Bressound PF. Hemophagocytic syndrome following an Epstein-Barr virus infection: a case report and literature review. J Ky Med Assoc 2000;98:161-5.

Su I, Chen R, Lin D, et al. Epstein-Barr Virus (EBV) infects T Iymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Path. 1994:144:1219-25.

Kikuta H, Sakiyama Y, Matsumoto S, Oh-Ishi T, Nakano T, Nagashima T, Oka T, Hironaka T, Hirai K Fatal Epstein-Barr Virus - associated hemophagocytic syndrome. Blood 1993;82:3259-64.

Faurschou M, Nielsen OJ, Hansen PB, Juhl BR, Hasselbaich H. Fatal virus - associated hemophagocytic syndrome associated with coexistent chronic active hepatitis B and acute hepatitis C' virus infection. Am J Hematol 1999;61:135-8.

Kyoda K, Nakamura S, Machi T, Kitagawa S, Ohtake S, Matsuda T. Acute hepatitis A virus infection associated hemophagocytic syndrome. Amer J Gastroenterol 1998;93:1187-8.

Shirono K, Tsuda H. Parvovirus B19 associated hemophagocytic syndrome in healty adults. Br J Haematol 1995,89:923-6.

Takagi M, Unno A, Maruyama T, Kaneko K, Obinata K. Human herpesvirus-6 (HHV-6) - associated hemophagocytic syndrome. Pediatr Hematol Oncol 1996;13:451-6.

Takeoka Y, Hino M, Oiso N, Nishi S, Koh KR, Yamane T, Ohta K, Nakamae H, Aoyama Y, Hirose A, Fujino H, Takubo T, Inoue T, Tatsumi N. Virus-associated hemophagocytic syndrome due to rubella virus and viricella-zoster virus dual infection in patient with adult idiopathic thrombocytopenic purpura. Ann Hematol 2001;80:361-4.

Nishiki S. B precursor lymphoblastic leukemial lymphoma manifested at on as hemophagocytic syndrome. Rinsho Byori 2000;48:975-9.

ถนอมศรี ศรีชัยกุล, วิเชียร มงคลศรีตระกูล. The So Called "Malignant Histiocytosis" ในตำราโลหิตวิทยา การวินิจัย และการรักษาโรคเลือดที่พบบ่อยในประเทศไทย บรรณาธิการ ถนอมศรี ศรีชัยกุล แสงสุรีย์ จูฑา บริษัท เมดิคัล มีเดีย จำกัด พ.ศ. 2547 หน้า 811-828.

Mitarnun W, Kietthubthew S, Suwiwat S. Hepatic peripheral T-cell lymphoma : A spectrum of liver pathology and clinical correlation. J Med Assoc Thai 1997780.219-32

Srichaikul T, Sonakul D, Meekungwal P, Prayoonwiwat W, Leelasiri A, Pornvicha P, Mongkonsritagoon W, Sriswasdi C. Pleomorphic large cell hemato-Lymphoma (The so called "maligmant histiocytosis"): clinicopathological and immunophenotypic studies in 35 cases. J Med Ass Thai 1994;77:588-98.

Intragumtomchai T, Sucharitchan P, Swasdikul D, Mahasantana S, Watananukul P. Malignant histiocytosis: a report of 67 cases. Chula Med J 1992,36:681-91.

Lekakul A. Peripheral T cell Lymphoma 2" National Conference of Lymphoma. มหาวิทยาลัยสงขลานครินทร์และสมาคมโลหิตวิทยาแห่งประเทศไทย 3-4 พฤษภาคม 2545 หน้า 28-37.

Falini B, Pileri S, De Solas I, Martelli MF, Mason DY, Delsol G, Gatter KC, Fagioli M. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 1990;36:681-91.

Allory Y, Challine D, Haioun C, Copie-Bergman C, Delfau-Larue MH, Boucher E, Charlotte F, Fabre M, Michel M, Gaulard P. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation. Am J Surgical Patho 2001,25:865-74.

Lampert I, Catovsky D, Bergier N. Malignant histiocytosis, a clinicopathological study of 12 cases. Brit J Haematol 1978;40:65-77.

Wamke R, Kim H, Dorfman R. Malignant histiocytosis (histocytic medullary reticulosis) clinicopathological study in 29 cases. Cancer 1975,35:215-30.

Gomyo H, Shimoyama M, Minagawa K, Yakushiu K, Urahama N, Okamura A, et al. Effective anti-viral therapy for hemophagocytic syndrome associated with B cell lymphoma. Leuk Lymphoma 2003;44:1807-10.

Okano M, Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. American Journal of Hematology 1996;53:111-5.

Ohshima K, Suzumiya J, Sugihara M, Nagafuchi S, Ohga S, Kikuchi M. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome. Pathol Int 1998;48:934-43.

Wong KF, Chan JKC, Lo ESF, Wong CSC. A study of the possible etiologic association of Esptein-Barr Virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Human Pathology 1996;27:1239-42.

d'Amore F, Johansen P, Houmand A, Weisenburger DD, Mortensen LS. Epstein-Barr virus Genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell Iymphoma and correlation with a poor prognosis.

Blood 1996;87:1045-55.

Imashuku S, Miyagawa A, Chiyonobu T, Ishida H, Yoshihara T, Kuriyama K, et al. EBV associated T lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a hypogammaglobulinemia, infectious, and myelokathexis. Ann. Hematol 200281:470-3.

Yao M, Cheng AL, Su IJ, Lin MT, Uen WC, Tien HF, Wang CH, Chen YC. Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma. Brit J Haematol 1994;87:535-43.

Mitamun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, Mori A. EBV associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic and molecular analysis. Amer J Hematology 2002;70:31-8.

Mitarnum W, Saechan V, Pradutkanchana J, Suwiwat Takao S, Ishida T. EBV associated peripheral T cell lymphoma with gastrointestinal tract involvement. J Med Assoc Thai 2003;86:816-28.

Su IJ, Wang CH, Cheng AC, Chen RL. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis and mangement. Leukemia and Lymphoma 1995,19:401-6.

Wilson M, Weiss L, Gatter K, Mason D, Dorfman R, Warnke R. Malignant histiocytosis a reassesment of cases previously report in 1975; based on paraffin section immunophenotypic studies. Cancer 1990;66.530-6.

Weiss L, Picker L, Copenhaver C, Warnke R, Sklar J. Large cell hematolymphoid neoplasms of uncertain lineage. Hum Pathol 1988;19:967-73.

Mason D, Bastard C, Rimokh R, Dastuge N, Huret J, Kristoffersson U, et al. CD30 positive large cell lymphoma (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5 q 35. Brit J Haematol 1990;74:161-8.

Onishi Y, Hotta S, Iwamoto H, Kamoshida T, Takahashi A, Imai Y. An autopsy case of intravascular malignant lymphomatosis with hemophagocytic syndrome, mental confusion and liver dysfunction. Rinsho Ketsueki 1998;39:586-92.

Miyahara M, Sano M, Shibata K, Matsuzaki M, Ibaraki K, Shimamoto Y, Tokunaga O. B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics. Ann Hematol 2000;79:378-88.

Shimazaki C, Inaba T, Shimura K, Okamoto A, Takahashi R, Hirai H, Sudo Y, Ashihara E, Adachi Y, Murakami S, Saigo K, Fuita N, Nakagawa M. B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haemato 1999;104:672-9.

Ohno t, Miyake N, Hada S, Hirose Y, Imura A, Hori T, et al. Hemophagocytic syndrome in five patients with EBV negative B cell lymphoma. Cancer 1998;82:1963-72.

Imashuku S, Hibi S, Tabata Y, Todo S. Hemophagocytic syndrome in five patients with EBV negative B-cell lymphoma. Cancer 1999;15:2298-300.

Kawa-Ha K, Ishihara S, Ninomiya T, Yamura-Yagi K, Hara J Murayama F, et al. CD3 negative lymphopro liferative disease of granular lymphocytes containing Epstein-Bar viral DNA.J Clin Invest 1989;84:51-4.

Hiroshima K, Iyoda A, Isobe K, Ishii G, Toyozaki T, Shibuya K, et al. Fatal infectious mononucleosis with evidence suggestive of the development of B cell lymphoma. Pathol. Int. 2003;53:642-8.

Kobbervig C, Norback D, Kahl B. Infectious mono-nucleosis progressing to fatal malignant lymphoma: a case report and review of the literatures. Leuk Lymphoma 2003;44:1215-21.

Imashuku S, Hibi S. Cytokines in hemophagocytic syndrome. Br J Haematol 1991;77:438-40.

Ohga S, Matsuzaki A, Nishizaki M, Nagashima T, KaiT, Suda M, Ueda K. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Am J Pediat Hematol Oncol 1993;15:291-8.

Partrick DA, Moore FA, Moore EE, Biff WL, Sauaia A, Barnett CC Jr. The inflammatory profile of interkeukin-6, interleukin-8 and soluble intercellular adhision molecule-1 impostinjury multiple organ failure.Am J Surg 1996;172:425-9.

Lay J, Tsao C, Chen J, Kadin M, Su I. Upregulation of tumor necrosis factor-O gene gy Esptein-Barr Virus

and activation of macrophages in Epstein-Barr Virus - infected T cells in the pathogenesis of hemophagocytic syndrome. Clin Invest 199710:1969-79.

Lay JD, Chuang SE, Rowe M, Su IJ. EBV-LMP1 mediates upregulation of TNF O in EBV - infeccted T cells: implication for the pathogenesis of hemophagocytic syndrome. J Biomed Sci 2003;10:146-55.

Allrecht H, Schafer H, Stelllbrink H, Greten H. Esptein-Barr virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1997;121:853-8.

Hayashi K, Ohara N, Teramoto N, Onoda S, Chen HI, Oka T, Kondo E, Yoshino T, Takahashi K, Yates J, Akagi T. An animal model for human EBV-associated hemophagocytic syndrome. Am J Pathol 2001;158:1533-42.

Ohshima K, Shimazaki K, Sugihara M, Haraoka S, Suzumiya J, Kanda M, Kawasaki C, Kiduchi M. Clincopathological findings of virus-associated hemophagocytic syndrome in bone marrow: association with Epstein-Barr virus and apoptosis. Pathol Int 1999,49:533-40.

Talag AH, Mohamed AE, Dafulla MM. Hemophagocytic syndrome. Saudi Med J 2000;21:979-82.

Mihara H, Kato Y, Tokura Y, Hattori Y, Sato A, Kobayashi H, Imamura A, Daimaru O, Miwa H, Nitta M. Esptein-Barr virus-associated hemophagocytic syndrome during mid-term pregnancy successfully treated with combined methylpredisolone and intravenous immunoglobulin. Rinsho Ketsueki 1999;40:1258-64.

Estlin EJ, Plamer RD, Windeband KP, et al. Successful treatment of non-familial haemophagocytic lymphohistiocytosis with interferon and gammaglobulin. Archives of Disease Childhood 1996;75:432-5.

Tsuda H, Shirono K. Successful treatment of virus- associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony- stimulating factor. British J Haematol 1996,93:572-5.

Omagari K, Ashida R, Oh-I H, Minamino Y, Sasaki O, Ozono Y, Maeda T, Sadamori N, Tomonaga M, Kohno S. Successful treatment with cyclosporine in a case of themophagocytic syndrome manifesting as severe liver dysfunction. Am J Med Sciences 1997314:403-7.

Erduran E, Gedik Y, Sen Y, Yildiran A. Successful treatment of reactive hemophagocytic syndrome with cyclosporin A and intravenous immunoglobulin. Turk J Pediatr 2000;42:168-70.

Rokyta R, Novak I, Matejovic M, Sramek V, Hora P, Jindra P. Hemophagocytic syndrome in the critically ill. Intensive Care Med 2000;26:1712.

Arico M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, Martinetti M, Rusca MP. Hemophagocytic lymphohistiocytosis diagnosis, treatment and prognosis in 122 children. Leukemia 1996;10:197.

ปัญญา เสกสรรค์. Hemophagocytic lymphohistiocytosis. ในโลหิตวิทยาในเวชปฏิบัติ บรรณาธิการ ธานินทร์ อินทรกำธรชัย. บริษัทมีบอนด์ เอ็นเทอร์ไพรซ์ จำกัด กทม. 2542 หน้า 270-278.

Henter JI, Elinder G, Soder O, Ost A. Incidence and clinical features of familial hemophagocytic lymphohistiocytosis in Sweden. Acta Paediatr Scand 1991,80:428.

Hanai M, Takei M, Yamazaki T, Morimoto K, Sawada U, Horie T. Successful treatment with intermittent administration of etoposide for an adult case with recurrent hemophagocytic syndrome, developed in association with chronic EB virus infection related lymphoid hyperplasia in the small intestine. Rinsho Ketsueki: - Japan J Clini Hemato 1997,38:682-8.

Imashuku S, Hibi S, Ohara T, Iwai A, Sako M, Kato M, Arakawa H, Sotomatsu M, Kataoka S, Asami K, Hasegawa D, Kosaka Y, Sano K, Igarashi N, Maruhashi K, Ichimi R, Kawasaki H, Maeda N, Tanizawa A, Arai K, Abe T, Hisakawa H, Miyashita H, Henter JI. Effective control of esptein-Barr virus-related hemophagocytic Iymphohistiocytosis with immunochemo-

therapy. Blood 1999;93:1869-74.

Matsumoto Y, Naniwa D, Banno S, Sugiura Y. The effcacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two cases reports. Ther Apher 1998;24:300-4

Satomi A, Nagai S, Nagai T, Nikura K, Ideura T, Ogata H, Akizawa T. Effect of plasma exchange on refractory hemophagocytic syndrome complicated with myelodysplastic syndrome. Ther Apher 1999,3:317-9.

Imashuku S, Hibi S, Todo S, Sako M, Inoue M, Kawa Koike K, Iwai A, Tsuchiya S, Akiyama Y, Kotani T, Kawamura Y, Hirosawa M, Hasegawa D, Kosaka Y, Yamaguchi H, Ishii E, Kato K, Ishii M, Kigasawa H. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplantation 1999;23:569-72.

Karasuno T, Teshima H, Hiraoka A, Nakamura H, Masaoka T. Successful bone marrow transplantation in an adult patient with reactive hemophagocytic syndrome associated with myelodysplastic syndrome. Int J Hematol 2000;71:180-3.

Downloads

Published

2022-12-30

Issue

Section

นิพนธ์ต้นฉบับ (Original article)